California State Teachers Retirement System Kinnate Biopharma Inc. Transaction History

California State Teachers Retirement System

$78.1 Billion
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$3.46 - $7.98 $2,771 - $6,391	-801 Reduced 6.87%	10,864 $67,000
Q4 2022 Feb 14, 2023	BUY	$5.26 - $12.19 $689 - $1,596	131 Added 1.14%	11,665 $71,000
Q3 2022 Nov 18, 2022	SELL	$9.86 - $15.76 $9,485 - $15,161	-962 Reduced 7.7%	11,534 $138,000
Q2 2022 Aug 15, 2022	SELL	$7.43 - $13.0 $58,355 - $102,102	-7,854 Reduced 38.59%	12,496 $158,000
Q1 2022 May 16, 2022	SELL	$7.73 - $17.99 $21,466 - $49,958	-2,777 Reduced 12.01%	20,350 $229,000

Q4 2021 Feb 15, 2022	BUY	$16.5 - $25.48 $4,785 - $7,389	290 Added 1.27%	23,127 $410,000
Q3 2021 Nov 15, 2021	BUY	$17.81 - $24.87 $73,555 - $102,713	4,130 Added 22.08%	22,837 $526,000
Q2 2021 Aug 16, 2021	SELL	$22.19 - $31.55 $37,234 - $52,940	-1,678 Reduced 8.23%	18,707 $435,000
Q1 2021 May 18, 2021	BUY	$26.99 - $40.0 $550,191 - $815,400	20,385 New	20,385 $635,000

Others Institutions Holding KNTE

# of Institutions

Shares Held

32.9M

Call Options Held

94.7K

Put Options Held

802K

View Full List

About Kinnate Biopharma Inc.

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

More about KNTE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account